These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2048974)

  • 21. Heparin-binding capacity of the HIV-1 NEF-protein allows one-step purification and biochemical characterization.
    Kohleisen B; Gaedigk-Nitschko K; Ohlmann M; Götz E; Ostolaza H; Goni FM; Erfle V
    J Virol Methods; 1996 Jun; 60(1):89-101. PubMed ID: 8795010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of humoral immune responses induced by immunization with plasmid DNA expressing HIV-1 Nef accessory protein.
    Moynier M; Kavsan V; Gales C; Montagnier L; Bahraoui E
    Vaccine; 1998 Oct; 16(16):1523-30. PubMed ID: 9711799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the HIV-1 Nef protein in the baculovirus system: investigation of anti-Nef antibodies response in human sera and subcellular localization of Nef.
    Kienzle N; Enders M; Buck M; Siakkou H; Jahn S; Petzold G; Schneweis KE; Bachmann M; Müller WE; Müller-Lantzsch N
    Arch Virol; 1992; 126(1-4):293-301. PubMed ID: 1524496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular Nef protein regulates productive HIV-1 infection from latency.
    Fujinaga K; Zhong Q; Nakaya T; Kameoka M; Meguro T; Yamada K; Ikuta K
    J Immunol; 1995 Dec; 155(11):5289-98. PubMed ID: 7594542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of a novel Nef epitope on the surface of HIV type 1-infected cells.
    Yamada T; Iwamoto A
    AIDS Res Hum Retroviruses; 1999 Jul; 15(11):1001-9. PubMed ID: 10445812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular localization of Nef expressed in persistently HIV-1-infected low-producer astrocytes.
    Kohleisen B; Neumann M; Herrmann R; Brack-Werner R; Krohn KJ; Ovod V; Ranki A; Erfle V
    AIDS; 1992 Dec; 6(12):1427-36. PubMed ID: 1301062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of synthetic peptides for the detection of antibodies against the nef regulating protein in sera of HIV-infected patients.
    Sabatier JM; Clerget-Raslain B; Fontan G; Fenouillet E; Rochat H; Granier C; Gluckman JC; Van Rietschoten J; Montagnier L; Bahraoui E
    AIDS; 1989 Apr; 3(4):215-20. PubMed ID: 2500954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody-dependent cellular cytotoxicity via humoral immune epitope of Nef protein expressed on cell surface.
    Yamada T; Watanabe N; Nakamura T; Iwamoto A
    J Immunol; 2004 Feb; 172(4):2401-6. PubMed ID: 14764710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody response to the negative regulatory factor (nef) in experimentally infected macaques: correlation with viremia, disease progression, and seroconversion to structural viral proteins.
    Kirchhoff F; Voss G; Nick S; Stahl-Hennig C; Coulibaly C; Frank R; Jentsch KD; Hunsmann G
    Virology; 1991 Jul; 183(1):267-72. PubMed ID: 1675823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies to HIV-1 nef(p27): prevalence, significance, and relationship to seroconversion.
    Cheingsong-Popov R; Panagiotidi C; Ali M; Bowcock S; Watkins P; Aronstam A; Wassef M; Weber J
    AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1099-105. PubMed ID: 2265027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and biochemical characterization of human immunodeficiency virus type 1 nef gene product.
    Kaminchik J; Bashan N; Pinchasi D; Amit B; Sarver N; Johnston MI; Fischer M; Yavin Z; Gorecki M; Panet A
    J Virol; 1990 Jul; 64(7):3447-54. PubMed ID: 2191151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relevance of anti-nef antibody detection as an early serologic marker of human immunodeficiency virus infection.
    Bahraoui E; Benjouad A; Sabatier JM; Allain JP; Laurian Y; Montagnier L; Gluckman JC
    Blood; 1990 Jul; 76(1):257-64. PubMed ID: 1694699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specificity of anti-Nef antibodies produced in mice immunized with DNA encoding the HIV-1 nef gene product.
    Moureau C; Moynier M; Kavsan V; Montagnier L; Bahraoui E
    Vaccine; 1999 Sep; 18(3-4):333-41. PubMed ID: 10506660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of immune responses induced after immunization with plasmids encoding the HIV-1 Nef protein under the control of the CMV-IE or the muscle-specific desmin promoter.
    Cazeaux N; Bennasser Y; Vidal PL; Li Z; Paulin D; Bahraoui E
    Vaccine; 2002 Sep; 20(27-28):3322-31. PubMed ID: 12213402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreasing levels of anti-Nef antibody correlate with increasing HIV type 1 viral loads and AIDS disease progression.
    Chen YM; Lin RH; Lee CM; Fu CY; Chen SC; Syu WJ
    AIDS Res Hum Retroviruses; 1999 Jan; 15(1):43-50. PubMed ID: 10024051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small heat shock protein 27: An effective adjuvant for enhancement of HIV-1 Nef antigen-specific immunity.
    Milani A; Bolhassani A; Shahbazi S; Motevalli F; Sadat SM; Soleymani S
    Immunol Lett; 2017 Nov; 191():16-22. PubMed ID: 28917624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic domains of the HIV-1 vif protein as recognized by human sera and murine monoclonal antibodies.
    Wieland U; Kratschmann H; Kehm R; Kühn JE; Näher H; Kramer MD; Braun RW
    AIDS Res Hum Retroviruses; 1991 Nov; 7(11):861-7. PubMed ID: 1760226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro cytocidal effects of human immunodeficiency virus type 1 Nef on unprimed human CD4+ T cells without MHC restriction.
    Fujii Y; Otake K; Tashiro M; Adachi A
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():2943-51. PubMed ID: 9000084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.